Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Visit

Matteo Della Porta

Matteo Della Porta

Humanitas Research Hospital

Current and emerging treatment options for LR-MDS-associated anemia following ESA failure

Current and emerging treatment options for LR-MDS-associated anemia following ESA failure

Matteo Della Porta • 13 Jun 2023

Predictors of ESA failure in patients with LR-MDS with severe anemia

Predictors of ESA failure in patients with LR-MDS with severe anemia

Matteo Della Porta • 13 Jun 2023

The COMMANDS study: luspatercept versus epoetin alfa for ESA-naïve lower-risk MDS-associated anemia

The COMMANDS study: luspatercept versus epoetin alfa for ESA-naïve lower-risk MDS-associated anemia

Matteo Della Porta • 13 Jun 2023

COMMANDS: luspatercept vs epoetin alfa for anemia in ESA-naive LR-MDS

COMMANDS: luspatercept vs epoetin alfa for anemia in ESA-naive LR-MDS

Matteo Della Porta • 9 Jun 2023

Real-world validation of the value of the IPSS-M for prognostication in patients with MDS

Real-world validation of the value of the IPSS-M for prognostication in patients with MDS

Matteo Della Porta • 27 May 2023

Accelerating translational research in MDS using AI-generated synthetic data

Accelerating translational research in MDS using AI-generated synthetic data

Matteo Della Porta • 27 Apr 2023

Combining molecular and clinical data to predict survival & transformation risk in patients with MDS

Combining molecular and clinical data to predict survival & transformation risk in patients with MDS

Matteo Della Porta • 27 Apr 2023

What can artificial intelligence bring to the diagnosis and management of MDS?

What can artificial intelligence bring to the diagnosis and management of MDS?

Matteo Della Porta • 27 Apr 2023